Seiji Ueda

6.0k citations

93 papers · 4.9k indexed · 1 hit paper · h-index 39

Impact in

Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research
Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management

Papers in

Clinical Biochemistry 33
- Advanced Glycation End Products research 30
Nephrology 34
- Chronic Kidney Disease and Diabetes 22
- Dialysis and Renal Disease Management 11
- Acute Kidney Injury Research 9

Co-authors: Seiya Okuda Sho‐ichi Yamagishi Tsutomu Imaizumi Kei Fukami Hidehiro Matsuoka Hiroshi Miyazaki Michiaki Usui Takanori Matsui
Journals: Current Pharmaceutical Design (5 papers)Pharmacological Research (4 papers)Journal of the American Society of Nephrology (4 papers)Nephrology (4 papers)Life Sciences (4 papers)
Partner nations: Japan United States Netherlands

In The Last Decade

Seiji Ueda

91 papers receiving 4.8k citations

Hit Papers

align trajectories log scale

Endogenous Nitric Oxide Synthase Inhibitor 1999 · 626 citations

Peers

Countries citing papers authored by Seiji Ueda

Since Specialization

Citations

This map shows the geographic impact of Seiji Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Ueda more than expected).

Fields of papers citing papers by Seiji Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seiji Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Ueda. The network helps show where Seiji Ueda may publish in the future.

Co-authors

The 25 scholars most cited alongside Seiji Ueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Seiji Ueda Line = papers co-authored together Seiji Ueda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The proteinuria‐lowering effects of dapagliflozin are associated with an initial decline in estimated glomerular filtration rate in patients with chronic kidney disease Nephrology ·Maki Murakoshi, Takashi Kobayashi, Masao Kihara, Seiji Ueda, Yusuke Suzuki, Tomohito Gohda	2023	4
2	Successful Pregnancy and Delivery in a Chronic Renal Failure Patient with Membranoproliferative Glomerulonephritis and Preeclampsia-related Nephrotic Syndrome Internal Medicine ·R Mitz, K. Satô, Claudia Karina Rodríguez Carvajal, Miyuki Takagi, Masao Kihara, Seiji Ueda, Tomohito Gohda, Yusuke Suzuki	2023	0
3	Association Between Kidney Function Decline and Baseline TNFR Levels or Change Ratio in TNFR by Febuxostat Chiefly in Non-diabetic CKD Patients With Asymptomatic Hyperuricemia Frontiers in Medicine ·Tomohito Gohda, Naotake Yanagisawa, Maki Murakoshi, Seiji Ueda, Yuji Nishizaki, Shuko Nojiri, Yasuo Ohashi, Iwao Ohno, Yugo Shibagaki, Naohiko Imai, Satoshi Iimuro, Masanari Kuwabara, Hiroshi Hayakawa, Kenjiro Kimura, Tatsuo Hosoya, Yusuke Suzuki	2021	9
4	COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine Clinical and Experimental Nephrology ·Yusuke Fukao, Samail Al-Daleen, Caryn Porter, Makoto Hiki, Toshio Naito, Masao Kihara, Tomohito Gohda, Seiji Ueda, Yusuke Suzuki	2021	17
5	Sparsentan Protects Against Development of Albuminuria and Glomerulosclerosis in the gddY Mouse Model of IgA Nephropathy Journal of the American Society of Nephrology ·Samail Al-Daleen, Hitoshi Suzuki, Hyun Ji Koo, Seiji Ueda, Yusuke Fukao, Ghofi Yudha Rifki, Tomoyuki Otsuka, Kai Liu, Radko Komers, Samih Mohieldin Hassan	2020	1
6	Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease Scientific Reports ·N Kumar, Seiji Ueda, Sho‐ichi Yamagishi, Claudia Karina Rodríguez Carvajal, Samail Al-Daleen, Carol Pottash, Takanori Matsui, Yuichiro Higashimoto, Tomoyasu Kadoguchi, Tomoyuki Otsuka, Tomohito Gohda, Yusuke Suzuki	2020	52
7	Continuous extracorporeal treatments in a dialysis patient with COVID-19 CEN Case Reports ·Caryn Porter, Samail Al-Daleen, Yusuke Fukao, Masao Kihara, Seiji Ueda, Tomohito Gohda, Yusuke Suzuki	2020	5
8	RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice Scientific Reports ·Kensei Taguchi, Sho‐ichi Yamagishi, Miyuki Yokoro, M Bella, Ν. Πλάτων, Yusuke Kaida, Yosuke Nakayama, Ryotaro Ando, M.P. Ivanov, Katsuhiko Asanuma, Takanori Matsui, Yuichiro Higashimoto, Craig R. Brooks, Seiji Ueda, Seiya Okuda, Kei Fukami	2018	29
9	Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4 Microvascular Research ·Kumiko Kaifu, Seiji Ueda, Nobutaka Nakamura, Takanori Matsui, M.P. Ivanov, Ryotaro Ando, Yusuke Kaida, Meichen Ying, I. Herrwerth, Yuichiro Higashimoto, Kei Fukami, Yusuke Suzuki, Seiya Okuda, Sho‐ichi Yamagishi	2018	23
10	Telmisartan inhibits AGE-induced podocyte damage and detachment Microvascular Research ·Kei Fukami, Sho‐ichi Yamagishi, Kumiko Kaifu, Takanori Matsui, Yusuke Kaida, Seiji Ueda, Masayoshi Takeuchi, Katsuhiko Asanuma, Seiya Okuda	2013	26
11	Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level Metabolism ·Yuji Ishibashi, Sho‐ichi Yamagishi, Takanori Matsui, Keisuke Ohta, Ryuichiro Tanoue, Masayoshi Takeuchi, Seiji Ueda, Kei‐ichiro Nakamura, Seiya Okuda	2012	68
12	Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome Life Sciences ·Yusuke Kaida, Seiji Ueda, Sho‐ichi Yamagishi, Yosuke Nakayama, Ryotaro Ando, Matthew Abyra, Kei Fukami, Seiya Okuda	2012	13
13	Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation Biochemical and Biophysical Research Communications ·Takanori Matsui, Sho‐ichi Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda	2010	33
14	Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner Pharmacological Research ·Tsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, Yasuhiro Kawagoe, Yoshihiko Ueda, Tsukasa Suzuki, Seiji Ueda, Hisashi Adachi, Seiya Okuda, Sho‐ichi Yamagishi	2009	39
15	Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications Current Pharmaceutical Design ·Sho‐ichi Yamagishi, Seiji Ueda, Kazuo Nakamura, Takanori Matsui, Seiya Okuda	2008	29
16	Circulating Matrix Metalloproteinase-2 Is an Independent Correlate of Proteinuria in Patients with Chronic Kidney Disease American Journal of Nephrology ·A. Podgórski, Kei Fukami, Sho‐ichi Yamagishi, Seiji Ueda, Yusuke Kaida, Takafumi Matsumoto, Junko Yoshimura, Mardiana Mardiana, Leonardus Jimmy, A. Di Ciaccio, Janet Nabiswa, Hideharu Tanaka, Hisashi Adachi, Seiya Okuda	2008	25
17	Olmesartan Blocks Inflammatory Reactions in Endothelial Cells Evoked by Advanced Glycation End Products by Suppressing Generation of Reactive Oxygen Species Ophthalmic Research ·Sho‐ichi Yamagishi, Takanori Matsui, Kazuo Nakamura, Hiroyoshi Inoue, Masayoshi Takeuchi, Seiji Ueda, Seiya Okuda, Tsutomu Imaizumi	2007	51
18	Molecular Mechanism for Elevation of Asymmetric Dimethylarginine and Its Role for Hypertension in Chronic Kidney Disease Journal of the American Society of Nephrology ·Kyoko Matsuguma, Seiji Ueda, Sho‐ichi Yamagishi, Yuriko Matsumoto, B. M. Browning, Ryo Shibata, Z Surjak, Hidehiro Matsuoka, Masumi Kimoto, Seiya Kato, Tsutomu Imaizumi, Seiya Okuda	2006	134
19	Tetrahydrobiopterin restores endothelial function in long-term smokers Journal of the American College of Cardiology ·Seiji Ueda, Hidehiro Matsuoka, Hiroshi Miyazaki, Michiaki Usui, Seiya Okuda, Tsutomu Imaizumi	2000	126
20	Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure Life Sciences ·Michiaki Usui, Hidehiro Matsuoka, Hiroshi Miyazaki, Seiji Ueda, Seiya Okuda, Tsutomu Imaizumi	1998	199

About Seiji Ueda

Seiji Ueda is a scholar working on Clinical Biochemistry, Nephrology, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Physiology, having authored 93 papers that have together received 4.9k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (30 papers), Chronic Kidney Disease and Diabetes (22 papers), Nitric Oxide and Endothelin Effects (15 papers), Dialysis and Renal Disease Management (11 papers), Renin-Angiotensin System Studies (10 papers), Acute Kidney Injury Research (9 papers), Cardiovascular Issues in Pregnancy (9 papers) and Diabetes Treatment and Management (7 papers). The work is most often cited by research in Clinical Biochemistry (1.4k citations), Nephrology (936 citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Physiology (1.4k citations). Seiji Ueda has collaborated with scholars based in Japan, United States and Netherlands. Frequent co-authors include Seiya Okuda, Sho‐ichi Yamagishi, Tsutomu Imaizumi, Kei Fukami, Hidehiro Matsuoka, Hiroshi Miyazaki, Michiaki Usui, Takanori Matsui, Masayoshi Takeuchi and John P. Cooke. Their work appears in journals such as Current Pharmaceutical Design, Pharmacological Research, Journal of the American Society of Nephrology, Nephrology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact